Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price reached a new 52-week high on Thursday . The company traded as high as $8.95 and last traded at $8.84, with a volume of 79433 shares trading hands. The stock had previously closed at $8.90.
Cybin Stock Performance
The company has a market cap of $1.31 billion and a price-to-earnings ratio of -37.08. The firm has a fifty day moving average price of $2.08 and a 200 day moving average price of $0.94.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
- Five stocks we like better than Cybin
- How to Use the MarketBeat Excel Dividend Calculator
- When Is the Best Time to Invest in Mutual Funds?
- What are earnings reports?
- Is NVIDIA Stock in a Correction or Consolidation?
- How to Effectively Use the MarketBeat Ratings Screener
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
